Literature DB >> 3572620

Childhood sequelae of infant lung disease: exercise and pulmonary function abnormalities after bronchopulmonary dysplasia.

D Bader, A D Ramos, C D Lew, A C Platzker, M W Stabile, T G Keens.   

Abstract

To determine the long-term pulmonary sequelae and effect on exercise tolerance of bronchopulmonary dysplasia (BPD), we studied 10 children at a mean age of 10.4 years, who had been born prematurely, survived respiratory distress syndrome, and subsequently developed BPD, and compared them with eight age-matched normal children born at term. Pulmonary function tests and graded exercise stress tests were performed. Residual volume, the ratio between residual volume and total lung capacity, vital capacity, forced expiratory volume in 1 second, forced expiratory flow between 25% and 75% of vital capacity, and maximal expiratory flows at 80%, 70%, and 60% of total lung capacity were all abnormal (P less than 0.02) in the children with BPD, compared with control values. Pre-exercise transcutaneous CO2 tension was higher (P less than 0.05) in the BPD group than in the control group. At maximal workload, tcPCO2 remained high in patients with BPD compared with control values (P less than 0.05). Arterial oxygen saturation at maximal workload fell below pre-exercise levels in the BPD group (P less than 0.05) but not in control children. There were no differences in maximal oxygen consumption between the BPD group and control children. Exercise-induced bronchospasm occurred in 50% of the BPD group, but not in the control group. We conclude that long-term survivors of BPD have evidence of airway obstruction, hyperinflation, and airway hyperreactivity, compared with a control group. Aerobic fitness was not significantly different in the BPD and control groups, but was achieved in the BPD group at the expense of a fall in SaO2 and a rise in tcPCO2.

Entities:  

Mesh:

Year:  1987        PMID: 3572620     DOI: 10.1016/s0022-3476(87)80004-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  24 in total

Review 1.  Long term sequelae of bronchopulmonary dysplasia (chronic lung disease of infancy).

Authors:  E Eber; M S Zach
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

Review 2.  Bronchopulmonary dysplasia: then and now.

Authors:  W H Northway
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

3.  Lung function in children of low birth weight.

Authors:  K N Chan; C M Noble-Jamieson; A Elliman; E M Bryan; M Silverman
Journal:  Arch Dis Child       Date:  1989-09       Impact factor: 3.791

Review 4.  Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia.

Authors:  Rita M Ryan; Qadeer Ahmed; Satyan Lakshminrusimha
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

5.  Exercise performance in very low birth weight children at the age of 7-12 years.

Authors:  E Baraldi; S Zanconato; C Zorzi; P Santuz; F Benini; F Zacchello
Journal:  Eur J Pediatr       Date:  1991-08       Impact factor: 3.183

6.  Bronchopulmonary dysplasia (infantile chronic lung disease).

Authors:  C D Lew
Journal:  West J Med       Date:  1988-10

Review 7.  Exercise and the child born prematurely.

Authors:  H Hebestreit; O Bar-Or
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

Review 8.  Trajectories of Lung Function in Infants and Children: Setting a Course for Lifelong Lung Health.

Authors:  Brian K Jordan; Cindy T McEvoy
Journal:  Pediatrics       Date:  2020-09-16       Impact factor: 7.124

9.  Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategies.

Authors:  Carl T D'Angio; William M Maniscalco
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

10.  Nasal continuous positive airway pressure and outcomes in preterm infants: A retrospective analysis.

Authors:  Gustavo Pelligra; Mohamed A Abdellatif; Shoo K Lee
Journal:  Paediatr Child Health       Date:  2008-02       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.